These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus. Momose Y; Arai S; Eto H; Kishimoto M; Okada M J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212 [TBL] [Abstract][Full Text] [Related]
8. Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus. Gao M; Sheng N; Yang X; Jiang Y Acta Derm Venereol; 2020 Feb; 100(4):adv00048. PubMed ID: 31774542 [No Abstract] [Full Text] [Related]
9. Variable presentations of subacute cutaneous lupus erythematosus. Balma-Mena A; Ho N J Cutan Med Surg; 2010; 14(4):195-8. PubMed ID: 20642992 [No Abstract] [Full Text] [Related]
10. Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine. Gaffney RG; Werth VP J Am Acad Dermatol; 2019 Apr; 80(4):1162-1164. PubMed ID: 30582995 [No Abstract] [Full Text] [Related]
11. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of hydroxychloroquine on cutaneous lupus erythematosus in a Japanese girl. Yamamoto T; Hiraiwa T J Dermatol; 2014 Apr; 41(4):357-9. PubMed ID: 24617496 [No Abstract] [Full Text] [Related]
13. Dramatic effect of hydroxychloroquine on lupus alopecia. Igari S; Yamamoto T J Dermatol; 2018 Feb; 45(2):194-197. PubMed ID: 29068087 [TBL] [Abstract][Full Text] [Related]
14. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus". Callen JP Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112 [No Abstract] [Full Text] [Related]
15. Cutaneous manifestations of connective tissue disease. McCammack E; Haggstrom AN Adolesc Med State Art Rev; 2011 Apr; 22(1):35-53. PubMed ID: 21815443 [TBL] [Abstract][Full Text] [Related]
16. Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment. Mauldin EA; Morris DO; Brown DC; Casal ML Vet Dermatol; 2010 Aug; 21(4):373-82. PubMed ID: 20374572 [TBL] [Abstract][Full Text] [Related]
17. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of topical calcineurin inhibitors as monotherapy or in combination with hydroxychloroquine in cutaneous lupus erythematosus. Avgerinou G; Papafragkaki DK; Nasiopoulou A; Arapaki A; Katsambas A; Stavropoulos PG J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):762-7. PubMed ID: 21707772 [TBL] [Abstract][Full Text] [Related]
19. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Pelle MT; Callen JP Arch Dermatol; 2002 Sep; 138(9):1231-3; discussion 1233. PubMed ID: 12224986 [TBL] [Abstract][Full Text] [Related]
20. Ototoxicity due to hydroxychloroquine: report of two cases. Johansen PB; Gran JT Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]